IFRS Issues and solutions for the pharmaceuticals and life sciences industry
The IFRS Issues and solutions for the pharmaceuticals and life sciences industries is our collected insight on the application of IFRS® Accounting Standards in this industry – reflecting the views of many practitioners in the pharmaceuticals and life sciences industries.
This edition has been updated in 2023 to reflect changes in IFRS Accounting Standards and interpretations as at that date. Each solution is based on a specified set of circumstances.
We hope you continue to find this publication useful in understanding the accounting for common transactions that are encountered in the pharmaceuticals and life sciences industries. By stimulating debate of these topics, we hope we will encourage consistent practices by the pharmaceuticals and life sciences industries in financial reporting under IFRS Accounting Standards. This consistency will be critical to the continued usefulness and transparency of pharmaceuticals and life sciences companies’ financial reporting.
